Home › Onyx confirms, rejects Amgen's $120-per-share bid
 

Keywords :   


Onyx confirms, rejects Amgen's $120-per-share bid

2013-06-30 21:11:06| Biotech - Topix.net

Onyx Pharmaceuticals Inc. on Sunday confirmed that it received an unsolicited takeover bid from Amgen Inc. for $120 per share.

Tags: bid confirms rejects onyx

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
More »